Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis

類似資料

• Therapy-related myelofibrosis does not appear to exist
  著者:: Masarova, Lucia, 等
  出版事項: (2017)
• Therapeutic Potential of JAK2 Inhibitors for the Management of Myelofibrosis
  著者:: Verstovsek, Srdan
  出版事項: (2010)
• Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis
  著者:: Masarova, Lucia, 等
  出版事項: (2017)
• An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis
  著者:: Rozovski, Uri, 等
  出版事項: (2017)
• Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation
  著者:: Newberry, Kate J., 等
  出版事項: (2017)